Durable Anticancer Activity Observed in Patients Whose Cancer Had Progressed Despite Prior Treatment With Chemotherapy and/or Immunotherapy
Safety and Tolerability Similar to Previously Reported Phase 1 Results in Patients with Non-Small Cell Lung Cancer
PR Newswire
THOUSAND OAKS, Calif., Oct. 5, 2020